Critical role of Dengue Virus NS1 protein in viral replication

Virologica Sinica

Volumn 29, Issue 3, 2014, Pages 162-169

  Fan, Jingjing ^a,b   Liu, Yi ^a,b   Yuan, Zhiming ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

dengue type 2 virus; glycosylation site; NS1; replication

Indexed keywords

ALANINE; ASPARAGINE; CYSTEINE; GLUTAMIC ACID; GLYCAN; NONSTRUCTURAL PROTEIN 1; VIRUS RNA; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BHK CELL LINE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DELETION MUTANT; DENGUE VIRUS; DENGUE VIRUS 2; DISULFIDE BOND; NONHUMAN; PHENOTYPE; RNA SYNTHESIS; RNA TRANSCRIPTION; SITE DIRECTED MUTAGENESIS; VERO CELL LINE; VIROGENESIS; VIRUS MUTANT; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE; GENETICS; METABOLISM; PHYSIOLOGY;

DENGUE VIRUS;

DENGUE VIRUS; MUTAGENESIS, SITE-DIRECTED; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84904325413     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-014-3459-1     Document Type: Article

References (35)

1. Akey D, Brown W, S Dutta, J Konwerski, J Jose, TJ Jurkiw, J DelProposto, CM Ogata, G Skiniotis, RJ Kuhn, and. J S. 2014. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science, 343: 881-885.
2. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, and Flamand M. 2002. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol, 40: 376-381. (Pubitemid 34130856)
3. Avirutnan P, Fuchs A, Hauhart R, Somnuke P, Youn S, Diamond M, and Atkinson J. 2010. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med, 207: 793-806.
4. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Jairungsri A, Kanlaya R, Tangthawornchaikul N, Puttikhunt C, Pattanakitsakul S, Yenchitsomanus P, Mongkolsapaya J, Kasinrerk W, Sittisombut N, Husmann M, Blettner M, Vasanawathana S, Bhakdi S, and Malasit P. 2006. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis, 193: 1078-1088.
5. Chambers T, Hahn C, Galler R, and Rice C. 1990. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol, 44:: 649-688.
6. Chang H, Shyu H, Wang Y, Sun D, Shyu R, Tang S, and Huang Y. 2002. Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. J Infect Dis, 186: 743-751. (Pubitemid 35013425)
7. Chen M, Lin C, Lei H, Lin S, Liu H, Yeh T, Anderson R, and Lin Y. 2009. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J Immunol, 183: 1797-1803.
8. Chung K, Liszewski M, Nybakken G, Davis A, Townsend R, Fremont D, Atkinson J, and Diamond M. 2006. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci U S A, 103: 19111-19116. (Pubitemid 350002836)
9. Crabtree M, Kinney R, and Miller B. 2005. Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses. Arch Virol, 150: 771-786. (Pubitemid 40560824)
10. Falgout B, and Markoff L. 1995. Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum. J Virol, 69: 7232-7243.
11. Flamand M, Megret F, Mathieu M, Lepault J, Rey F, and Deubel V. 1999. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation- dependent fashion. J Virol, 73: 6104-6110. (Pubitemid 29274901)
12. Fuchs A, Lin T, Beasley D, Stover C, Schwaeble W, Pierson T, and Diamond M. 2010. Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin. Cell Host Microbe, 8: 186-195.
13. Hoang L, Lynn D, Henn M, Birren B, Lennon N, Le P, Duong K, Nguyen T, Mai L, Farrar J, Hibberd M, and Simmons C. 2010. The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol., 84: 12982-12994.
14. Hori H, and Lai C-J. 1990. Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C-terminus of NS1. J Virol, 64: 4573-4577. (Pubitemid 20279874)
15. Jia F, Fan J, Zhang B, and Yuan Z. 2013. Mutagenesis of D80-82 and G83 residues in West Nile Virus NS2B: effects on NS2B-NS3 activity and viral replication. Virol Sin, 28: 16-23.
16. Kyle J, and Harris E. 2008. Global spread and persistence of dengue. Annu Rev Microbiol, 62: 71-92.
17. Lin C, Lei H, Shiau A, Liu C, Liu H, Yeh T, Chen S, and Lin Y. 2003. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol, 69: 82-90. (Pubitemid 35403658)
18. Lin S, Zou G, Hsieh S, Qing M, Tsai W, Shi P, and Wang W. 2011. The Helical Domains of the Stem Region of Dengue Virus Envelope Protein Are Involved in both Virus Assembly and Entry. J Virol, 85: 5159-5171.
19. Lindenbach B, and Rice C. 1997. Trans-complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol, 71: 9608-9617. (Pubitemid 27492408)
20. Mackenzie J, Jones M, and Young P. 1996. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology, 220: 232-240. (Pubitemid 26201681)
21. Muylaert I, Chambers T, Galler R, and Rice C. 1996. Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology, 222: 159-168. (Pubitemid 26281367)
22. Pletnev A, Bra M y, and La C i. 1993. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. J Virol, 67: 4956-4963.
23. Pryor M, and Wright P. 1993. The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus. Virology, 194: 769-780.
24. Pryor M, and Wright P. 1994. Glycosylation mutants of dengue virus NS1 protein. J Gen Virol, 75: 1183-1187. (Pubitemid 24143165)
25. Pryor M, Gualano R, Lin B, Davidson A, and Wright P. 1998. Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins. J Gen Virol, 79: 2631-2639. (Pubitemid 28497615)
26. Somnuke P, Hauhart R, Atkinson J, Diamond M, and Avirutnan P. 2011. N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. Virology, 413: 253-264.
27. Sun D, King C, Huang H, Shih Y, Lee C, Tsai W, Yu C, and Chang H. 2007. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost, 5: 2291-2299. (Pubitemid 47617883)
28. Tajima S, Takasaki T, and Kurane I. 2008. Characterization of Asn130-to-Ala mutant of dengue type 1 virus NS1 protein. Virus Genes, 36: 323-329.
29. Vaughn D, Green S, Kalayanarooj S, Innis B, Nimmannitya S, Suntayakorn S, Endy T, Raengsakulrach B, Rothman A, Ennis F, and Nisalak A. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis, 181: 2-9. (Pubitemid 30049026)
30. Westaway E, Mackenzie J, Kenney M, Jones M, and Khromykh A. 1997. Ultrastructure ofKunjin virus-infected cells: colocalization of NS1 and NS3 with doublestranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J Virol, 71: 6650- 6661.
31. Whiteman M, Li L, Wicker J, Kinney R, Huang C, Beasley D, Chung K, Diamond M, Solomon T, and Barrett A. 2010. Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus. Vaccine, 28: 1075-1083.
32. WHO. 2012. Global strategy for dengue prevention and control 2012-2020. WHO Library Cataloguing-in-Publication Data, Switzerland.
33. Winkler G, Maxwell S, Ruemmler C, and Stollar V. 1989. Newly synthesized dengue-2 virus nonstructural proteinNS1 is a soluble protein but becomespartially hydrophobic and membrane-associated after dimerization. Virology, 171: 302-305. (Pubitemid 19180804)
34. Winkler G, Randolph V, Cleaves G, Ryan T, and Stollar V. 1988. Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology, 162: 187-196. (Pubitemid 18063113)
35. Young P, Hilditch P, Bletchly C, and Halloran W. 2000. An antigen capture enzymelinked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol, 38: 1053-1057. (Pubitemid 30140558)